SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-256027
Filing Date
2022-10-03
Accepted
2022-10-03 06:07:02
Documents
13
Period of Report
2022-09-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d403495d8k.htm   iXBRL 8-K 24710
2 EX-99.1 d403495dex991.htm EX-99.1 10321
  Complete submission text file 0001193125-22-256027.txt   159957

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA myov-20220930.xsd EX-101.SCH 2845
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE myov-20220930_lab.xml EX-101.LAB 17927
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE myov-20220930_pre.xml EX-101.PRE 11230
7 EXTRACTED XBRL INSTANCE DOCUMENT d403495d8k_htm.xml XML 3359
Mailing Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB
Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB 44 207-400-3351
Myovant Sciences Ltd. (Filer) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37929 | Film No.: 221285814
SIC: 2834 Pharmaceutical Preparations